EYE 11.6% 24.0¢ nova eye medical limited

Ann: i Track Advance Sales in the USA, page-28

  1. 3,740 Posts.
    lightbulb Created with Sketch. 106
    To be clear sales growth is a good thing, and this is quite a quick uptick over baseline, I just think it’s premature to get excited at one data point, if however new users love the device and increase their volumes the growth can compound, if those users spread the word an increase uptake in new users alongside company push growth could compound again. 1.3 * 1.3 * 1.3 becomes an exciting trajectory.

    it’s hypocritical to say that watching short term share price changes is invalid when one gets excited by very short term sales updates.
 
watchlist Created with Sketch. Add EYE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.